GB1290593A - - Google Patents
Info
- Publication number
- GB1290593A GB1290593A GB1290593DA GB1290593A GB 1290593 A GB1290593 A GB 1290593A GB 1290593D A GB1290593D A GB 1290593DA GB 1290593 A GB1290593 A GB 1290593A
- Authority
- GB
- United Kingdom
- Prior art keywords
- hydrocarbon radical
- april
- optionally substituted
- alk
- cardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004215 Carbon black (E152) Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 230000000747 cardiac effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001299 aldehydes Chemical class 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 101150009274 nhr-1 gene Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004089 psychotropic agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH519069A CH529721A (de) | 1969-04-03 | 1969-04-03 | Verfahren zur Herstellung neuer Hydroxy-Amine |
| CH545069 | 1969-04-09 | ||
| CH228070 | 1970-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1290593A true GB1290593A (enExample) | 1972-09-27 |
Family
ID=27173592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1290593D Expired GB1290593A (enExample) | 1969-04-03 | 1970-04-03 |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU1320070A (enExample) |
| DE (1) | DE2014346A1 (enExample) |
| ES (1) | ES378163A1 (enExample) |
| FR (1) | FR2038200A1 (enExample) |
| GB (1) | GB1290593A (enExample) |
| NL (1) | NL7004728A (enExample) |
| OA (1) | OA03248A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3205457A1 (de) * | 1982-02-16 | 1983-08-25 | Merck Patent Gmbh, 6100 Darmstadt | Oxazolidin-2-one |
-
1970
- 1970-03-20 FR FR7010158A patent/FR2038200A1/fr not_active Withdrawn
- 1970-03-25 DE DE19702014346 patent/DE2014346A1/de active Pending
- 1970-03-31 AU AU13200/70A patent/AU1320070A/en not_active Expired
- 1970-04-02 NL NL7004728A patent/NL7004728A/xx unknown
- 1970-04-02 ES ES378163A patent/ES378163A1/es not_active Expired
- 1970-04-03 GB GB1290593D patent/GB1290593A/en not_active Expired
- 1970-04-03 OA OA53893A patent/OA03248A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2038200A1 (enExample) | 1971-01-08 |
| DE2014346A1 (de) | 1970-10-08 |
| NL7004728A (enExample) | 1970-10-06 |
| AU1320070A (en) | 1971-10-07 |
| OA03248A (fr) | 1970-12-15 |
| ES378163A1 (es) | 1973-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP19971265B (en) | Substituted sulphonamides,, the substituted cyclic amines in the form of intermediate compounds for reception of the substituted sulphonamides and the pharmaceutical composition on the basis of the substituted sulphonamides displaying activity towards thromboxane receptors | |
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1301973A (enExample) | ||
| GB1257225A (enExample) | ||
| GB1297080A (enExample) | ||
| GB1362845A (en) | Benzyl alcohol derivatives | |
| GB1270049A (en) | New pharmaceutical product | |
| GB1237352A (en) | Substituted propylamines | |
| GB1361198A (en) | Disulphide compounds and process for their manufa'ture | |
| IE34609B1 (en) | Antineoplastic therapeutic compositions | |
| GB1346279A (en) | Hydantoin derivatives processes for their preparation and compositions incorporating them | |
| GB1404607A (en) | Process for the photocyclization of dihydro-ionones and their | |
| GB1331161A (en) | Amino-s-triazolylbenzenesulphonamides | |
| GB1290300A (enExample) | ||
| GB1414032A (en) | Intermediate sulphamides | |
| ES368398A1 (es) | Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-ter-butilaminopropanos sustituidos. | |
| GB1480579A (en) | Substituted alkylenediamines | |
| GB1395929A (en) | Thioureas | |
| GB1132397A (en) | Improvements in or relating to fluorene derivatives and the manufacture thereof | |
| GB1290468A (enExample) | ||
| GB1373271A (en) | Indoles | |
| GB1340535A (en) | Benzodiazepine derivatives | |
| GB1266430A (enExample) | ||
| GB1185616A (en) | 2-Sulfanilamido-3-Halogeno-Pyridines | |
| GB1254948A (en) | Antivirial substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |